Please Note: This event has expired.

Daniel Ollendorf, Chief Scientific Officer, Institute for Clinical and Economic Review
This presentation will discuss value assessment—including the use of cost-effectiveness and budgetary impact analyses in decision-making—and will contrast approaches taken in other high-income countries with those in the U.S. Daniel Ollendorf will touch on what is included in the umbrella under the term “value-based pricing,” and discuss under what circumstances various approaches to negotiation, such as outcomes-based contracting, amortized payments, and negotiated discounts may or may
View moreADMISSION INFO
LOCATION
72 East Concord Street, 14th Floor, Boston, MA 02118